Jill Kompa

Company: Novartis

Job title: Senior Global Program Regulatory Director, RA lead Cardiovascular-Metabolism

Seminars:

Navigating the Regulatory Landscape of Obesity Therapeutics to Understand How to Improve Patient Treatment 9:01 am

Learn about the evolving regulatory landscape for obesity medications, including clinical trial design, data requirements, and regulatory approval processes to drive your drugs towards clinic. Understanding the evolving regulatory guidelines and approval pathways for obesity medications, and how to measure obesity beyond BMI Gaining insights into the challenges and considerations for navigating the regulatory process…Read more

day: Pre-Conference Day